An Ecological Study of the Role of Obesity and Excessive Alcohol Consumption on the Risk for Epithelioid Hemangioendothelioma Cancer of the Liver, Lungs, and Bones

Brina M. Hollis^1,

¹School of Health Sciences, Kaplan University, Florida, USA

Cite this paper:
Brina M. Hollis. An Ecological Study of the Role of Obesity and Excessive Alcohol Consumption on the Risk for Epithelioid Hemangioendothelioma Cancer of the Liver, Lungs, and Bones. American Journal of Public Health Research. 2014; 2(4):170-175. doi: 10.12691/ajphr-2-4-7

Abstract

Purpose: To examine excessive alcohol consumption and obesity as risk factors for epithelioid hemangioendothelioma (EHE) of the liver, lungs, and bones. Methods: The nine tenets of the Bradford Hill criteria of epidemiological causation served as the conceptual framework of this study. Documented cases of EHE of the liver, lungs, and bones were collected from the International Hemangioendothelioma Epithelioid and Related Vascular Disorders registry database. A secondary data analysis was conducted using the Behavioral Risk Factor Surveillance System telephone survey. US census data were employed to obtain regional demographic data that were used as covariate controls for the study. Correlation and regression analyses were conducted to examine relationships among the rates of regional obesity, alcohol consumption, and prevalence of EHE of the liver, lungs, and bones. Results: Obesity proved to be a significant predictor of EHE of the liver, lungs, and bones; excessive alcohol consumption was not a significant predictor. Income was found to be a statistically significant covariate. Conclusions: The results highlight the need for research further examining the link between obesity and EHE. Knowledge of potential risk factors may facilitate greater understanding of this rare cancer and the development of improved protocols to expand EHE screening and documentation.

Keywords:
epithelioid hemangioendothelioma obesity alcohol consumption

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Maklouf H, Ishak K, Goodman Z. Epithelioid hemangioendothelioma of the liver: A clinicopathologic study of 137 cases. Cancer 1999; 85: 562-582.
[2]	National Library of Medicine Medical subject headings (MeSH) 2008. Hemangioendothelioma. Retrieved from http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Hemangioendothelioma,+Epithelioid&field=entry.
[3]	National Cancer Institute Surveillance Epidemiology and End Results 2008. Retrieved from http://seer.cancer.gov.
[4]	Chen TM, Donington J, Mak G, Berry GJ, Ruoss SJ, Rosen GD, et al. Recurrence of pulmonary intravascular bronchoalveolar tumor with mediastinal metastasis 20 years later. Respir Med 2006; 100 (2): 367-370.
[5]	Díaz R, Segura A, Calderero V, Cervera I, Aparicio J, Jordá MV, et al. Central nervous system metastases of a pulmonary epithelioid haemangioendothelioma. Eur Respir J 2004; 23 (3): 483-486.
[6]	Dail DH, Liebow AA, Gmelich JT, Friedman PJ, Miyai K, Myer W, et al. Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT): An analysis of twenty cases of a peculiar sclerosing endothelial tumor. Cancer 1983; 51: 452-464.
[7]	Posligua L, Anatelli F, Dehner LP, Pfeifer JD. Primary peritoneal epithelioid hemangioendothelioma. Int J Surg Pathol 2006; 14 (3): 257-267.
[8]	Sormunen C. Terminology for allied health professionals. Clifton Park: Thomson Delmar Learning; 2003.
[9]	Pusztaszeri M, Bosman F, Seelentag W. Immunohistochemical expression of endothelial markers. J Histochem Cytochem 2006; 54: 385-395.
[10]	Miller WJ, Dodd GD III, Federle MP, Baron RL. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 1992; 159: 53-7.
[11]	Mallory FB. The results of the application of special histological methods to the study of tumors. J Exp Med 1908; 10 (5): 575-593.
[12]	Mascarenhas RC, Sanghvi AN, Friedlander L, et al. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology. 2004; 67: 471-5.
[13]	Pokharna, Rupesh K., Pramod Kumar Garg, Siddhartha Datta Gupta, Usha Dutta, and Rakesh K. Tandon. "Primary epithelioid haemangioendothelioma of the liver: case report and review of the literature." Journal of clinical pathology 50, no. 12 (1997): 1029-1031.
[14]	Earnest IV, Frank, and C. Daniel Johnson. "Case 96: Hepatic Epithelioid Hemangioendothelioma 1." Radiology 240, no. 1 (2006): 295-298.
[15]	Hristov EN, Krishnamurthy S, Ro JY, Ayala AG. Pulmonary epithelioid hemangioendothelioma with prominent signet ring cell features mimicking metastatic adenocarcinoma. Ann Diagn Pathol 2003; 7 (3); 160.
[16]	Kabukcuoglu, Fevziye, Yavuz Kabukcuoglu, Ayten Livaoglu, Aysim Ozagari, Raffi Armagan, and Unal Kuzgun. "Epithelioid hemangioendothelioma of bone." Acta orthopaedica et traumatologica turcica 40, no. 4 (2004): 324-328.
[17]	Pins, M. R., H. J. Mankin, R. J. Xavier, D. I. Rosenthal, G. R. Dickersin, and A. E. Rosenberg. "Malignant epithelioid hemangioendothelioma of the tibia associated with a bone infarct in a patient who had Gaucher disease." JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME-77 (1995): 777-777.
[18]	Yoshida, Haruhiko, Mari Watanabe, Takeshi Minamizaki, and Nobuyuki Takasu. "Multicentric epithelioid hemangioendothelioma of the bone: histologic and radiographic features." Yonago Acta Med 43 (2000): 87-92.
[19]	Hermann G, Klein M, Abdelwahad I, Springfield D. (2002). Clear cell sarcoma (malignant melanoma of soft parts): case report and review of the literature. Can Assoc Radiol J 2002; 53 (4): 237-241.
[20]	Mucha K. Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years’ observation. Transpl P 2006; 38 (1): 231-233.
[21]	Tsarouha, Haroula, Anastasios I. Kyriazoglou, Franclim R. Ribeiro, Manuel R. Teixeira, Niki Agnantis, and Nikos Pandis. “Chromosome analysis and molecular cytogenetic investigations of an epithelioid hemangioendothelioma.” Cancer genetics and cytogenetics 169, no. 2 (2006): 164-168.
[22]	Theurillat J-P, Vavricka S, Went P, Weishaupt D, Perren A, Leonard-Meier C, et al. Morphologic changes and altered gene expression in an epithelioid hemangioendothelioma during a ten-year course of disease. Pathol Res Pract 2003; 199: 165-170.
[23]	Marsh D. Breast implants as a possible etiology of epithelioid hemangioendothelioma and successful therapy with Interferon-α2. The Breast Journal 2005; 11 (4): 257-261.
[24]	American Cancer Society 2007. Cancer facts and figures, 2007. Retrieved from http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf.
[25]	Adams SL. Heavy alcohol consumption increased risk for prostate cancer. Hem/Onc Today, 2009; 10 (16): 25.
[26]	Adams SL. Obesity, smoking, alcohol consumption related to risk for contralateral breast cancer. Hem/Onc Today, 2009; 10 (19): 30.
[27]	Harris J. Alcohol consumption increased risk for breast cancer recurrence by 34%. Hem/Onc Today 2010; 11 (1): 14.
[28]	Wong, A. W. (2010). Alcohol Consumption and Breast Cancer. Cur Med Lit: Breast Canc 2010; 22 (2): 41-47.
[29]	Centers for Disease Control 2008. Quick stats general information on alcohol use and health. Retrieved from http://www.cdc.gov/alcohol/quickstats/general_info.htm.
[30]	World Health Organization 2006. Cancer. Retrieved from http://www.who.int/mediacentre/factsheets/fs297/en/.
[31]	Centers for Disease Control 2008. Alcohol and public health. Retrieved from http://www.cdc.gov/alcohol/index.htm.
[32]	Höfler, M. (2005). The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol 2005;2:11.
[33]	Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C. (2004). Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 2004; 99 (8): 1024-1033.
[34]	Haneuse S, Wakefield J. (2007). Hierarchical models for combining ecological and case-control data. Biometrics 2007; 63 (1): 128-136.
[35]	Dumitrescu, R. G., and I. Cotarla. “Understanding breast cancer risk‐where do we stand in 2005?.” Journal of cellular and molecular medicine 9, no. 1 (2005): 208-221.
[36]	Frisbee J. (2007). Vascular dysfunction in obesity and insulin resistance. Microcirculation 2007; 14 (4-5): 269-271.
[37]	Mokdad, Ali H., Wayne H. Giles, Barbara A. Bowman, George A. Mensah, Earl S. Ford, Suzanne M. Smith, and James S. Marks. “Changes in health behaviors among older Americans, 1990 to 2000.” Public Health Reports 119, no. 3 (2004): 356.
[38]	H.E.A.R.D Support Group. The International H.E.A.R.D. Registry. Retrieved from http://www.H.E.A.R.D.support.org/registry.html